期刊文献+

中医药论治胃癌癌前病变的临床研究进展 被引量:3

The Progressment of Clinical Research about the Traditional Chinese Medicine Treat the Precancerous Lesions of Gastric Cancer
下载PDF
导出
摘要 慢性萎缩性胃炎(CAG)伴肠化、不典型增生被认定为胃癌癌前病变,癌变率可达10%—15%。众医家一致认为饮食不节、情志失调、过度劳累、久病体虚、素体虚弱为主要病因。气滞、血瘀、痰湿、湿热、食积、热毒等病理因素常单一或相互交错而致病,久之致胃癌癌前病变的发生。本病病因病机多相互影响,病性多虚实夹杂,病位在胃,与脾、肝、肾密切相关,目前尚无统一的辨证分型。西医治疗多为对症处理,效果一般。中医对此病有独特的优势,以整体观念、辨证论治为原则,实行个体化治疗,可在很大程度上逆转肠化和不典型增生。 Chronic atrophic gastritis(CAG) with intestinal metaplasia, atypical hyperplasia is considered as the precancerous lesions of Gastric cancer, the cancer rate can reach to 10%--15% . Most doctors agree with that the main causes of disease are improper diet, disorder emotions, overstrain valetudinarianism innate weakness.The pathological factors such as Qi stagnation, blood stasis, phlegm-dampness, damp-heat, dyspepsia, heat-posion and so on often occur singlely or cross-cuttingly.After a long time, they lead to the precancerous lesion of Gastric cancer. The cause of disease and pathological mechanism are often affect each other. Most of the nature of disease are deficiency syndrome and excess syndrome, the location of disease is at stomach, and has closely related with spleen, liver, kidney. At present, it has not uniform typing according to syndrome differentiation. The measures of western medicine are symptomatic treatment, the effect are not obvious. But traditional Chinese medicine' has unique advantage, for it use conception of holism, syndrome differentiation and treatment as cardinal principle, practice individual treatment, so it can reverse intestinal metaplasia and atypical hyperplasia in a large degree.
作者 殷洁 龙惠珍
出处 《光明中医》 2008年第8期1227-1228,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 胃癌 癌前病变 中医药疗法 临床研究进展 Gastric cancer, precancerous lesions of Gastric cancer, the traditional Chinese medicine treatment, progressment of clinical research
  • 相关文献

参考文献19

二级参考文献50

  • 1张运贵,张瑞玲,黄咏梅,段学萍,薛强,孙兆田.胃复春对胃癌癌前病变的治疗及对p21^(ras)、p53表达的调节作用研究[J].临床消化病杂志,2004,16(4):161-162. 被引量:16
  • 2刘增巍,沈洪.近年来胃癌癌前病变的中医药治疗进展[J].河南中医,2004,24(5):80-82. 被引量:4
  • 3李益农 萧树农 等.慢性胃炎的诊治问题[J].中华内科杂志,1983,22(5):257-262.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中华人民共和国卫生部,1995.10-15.
  • 5全国胃癌防治研究协作组 病理组.胃及十二指肠黏膜活检病理[M].沈阳:辽宁人民出版社,1981.27.
  • 6[2]Sippoen P,Hycarinen H,Seppala K,et al.Relationship between Helicobacter pylori, atrophie gastric cancer[J]. Alimentary Pharmacology Therapeutics,1989,12(Suppl)1:25-36.
  • 7[3]Kuipers EJ,Appelmelk BJ.Helicobecter pylori and atrophic gastritis[J].Biomedicine Phamacotherapy,1997,51:150-155.
  • 8[4]Fang DC,Liu WW.Subtypes of intestinal metaplasis and gastric carcinoma:aclinicoendoscopic follow-up of 112 cases[J].China Meb J,1991,104(6):467-471.
  • 9王永炎.中医内科学[M].上海:上海科学技术出版社,2003.124-131.
  • 10中华人民共和国卫生部.中药新药临床研究指导原则[s].北京:人民卫生出版社,1993.28~30.

共引文献187

同被引文献69

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部